Michael Mancino is a Psychiatry physician affiliated with University of Arkansas for Medical Sciences. OpenAlex indexes 62 publications with 889 citations (h-index 16); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4301 W Markham St # 783
Little Rock, AR 722057101
Telephone
501-686-8000Registry record last updated 16 Oct 2009.
Clinical trials
- Improving Treatment Outcomes for Prescription Opioid Dependence
Sponsor: University of Arkansas
- Modafinil for Methamphetamine Dependence
Sponsor: University of Arkansas
- Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study
Sponsor: University of Arkansas
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
3 NIH research awards on record, funded 2010–2019 per NIH RePORTER. The latest:
- Improving Treatment Outcomes for Prescription Opioid Dependence
Univ of Arkansas for Med Scis
FY2019$537,833R01DA039088 - Improving Treatment Outcomes for Prescription Opioid Dependence
Univ of Arkansas for Med Scis
FY2018$578,697R01DA039088 - Improving Treatment Outcomes for Prescription Opioid Dependence
Univ of Arkansas for Med Scis
FY2017$578,697R01DA039088
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Geospatial ecological momentary assessment (GEMA) for opioid use disorder: Protocol for a just-in-time adaptive intervention
Journal of Substance Use and Addiction Treatment
2026 - Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
The American Journal of Drug and Alcohol Abuse
2025 - A randomized clinical trial of disulfiram at higher doses for the treatment of cocaine use disorder among methadone-stabilized patients
Journal of Psychiatric Research
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Maurizio Zangari, MD
University of Arkansas for Medical Sciences
Everett Magann, MD
University of Arkansas for Medical Sciences
Analiz Rodriguez, MD, PhD
University of Arkansas for Medical Sciences
Jorge Saucedo, MD
University of Arkansas for Medical Sciences
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”